Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist (NIV NAVA) Versus Nasal Continuous Airway Pressure (NCPAP) in Premature Infants

University of Oulu1 site in 1 country40 target enrollmentAugust 2011

ConditionsRespiratory Distress Syndrome (RDS) of Neonate

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Respiratory Distress Syndrome (RDS) of Neonate
Sponsor: University of Oulu
Enrollment: 40
Locations: 1
Primary Endpoint: Duration of inspired oxygen supply
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to compare if a new noninvasive ventilation mode (NIV NAVA) is better in noninvasive ventilation of premature infants than currently used Nasal Continuous Airway Pressure (ncpap), and if NIV NAVA gives real benefits for patients or not.

The investigators study hypothesis is that with NIV NAVA the invasive ventilation is more synchronous with patient, which will lead to a decrease in need of inspired oxygen.

Registry

clinicaltrials.gov

Start Date

August 2011

End Date

May 2016

Last Updated

9 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

University of Oulu

Responsible Party

Principal Investigator

Merja Ålander

Principal investigator

University of Oulu

Eligibility Criteria

Inclusion Criteria

•postconceptional age 28+0 - 36+6
•need of ncpap treatment and inspired oxygen for at least 60 minutes

Exclusion Criteria

•severe birth asphyxia, malformation or chromosomal abnormality, or other condition, which will decrease life expectancy
•any condition which prevents insertion of naso/orogastric tube